2024
Coexistent Eosinophilic Esophagitis and Dysplastic Barrett's Esophagus With Rapid Eosinophilic Infiltration of Neosquamous Mucosa After Radiofrequency Ablation
Ameyaw P, Parsons D, Mahmoud A, Marie R, Nagar A, Aslanian H. Coexistent Eosinophilic Esophagitis and Dysplastic Barrett's Esophagus With Rapid Eosinophilic Infiltration of Neosquamous Mucosa After Radiofrequency Ablation. ACG Case Reports Journal 2024, 11: e01488. PMID: 39221230, PMCID: PMC11361630, DOI: 10.14309/crj.0000000000001488.Peer-Reviewed Original ResearchBarrett's esophagusRadiofrequency ablationDysplastic BEEosinophilic esophagitisOutcomes of radiofrequency ablationNeosquamous mucosaAssociation of gastroesophageal reflux diseaseEndoscopic eradication therapyDysplastic Barrett's esophagusGastroesophageal reflux diseaseEradication therapyEosinophil infiltrationReflux diseasePatientsEsophagealEoEEsophagusMucosaAblationRadiofrequency
2022
Evaluation and Management of the Patient with a Pancreatic Cyst
Göktürk S, Muniraj T, Aslanian H. Evaluation and Management of the Patient with a Pancreatic Cyst. 2022, 415-430. DOI: 10.1007/978-3-030-41683-6_27.Peer-Reviewed Original Research
2021
Evaluation and Management of the Patient with a Pancreatic Cyst
Göktürk S, Muniraj T, Aslanian H. Evaluation and Management of the Patient with a Pancreatic Cyst. 2021, 1-16. DOI: 10.1007/978-3-030-37482-2_27-1.Peer-Reviewed Original ResearchPancreatic Neuroendocrine Tumors
Muniraj T, Aslanian H. Pancreatic Neuroendocrine Tumors. 2021, 1933-1951. DOI: 10.1007/978-3-030-30192-7_81.Peer-Reviewed Original ResearchNeuroendocrine tumorsProlongs disease-free survivalDiagnosis of NETsNon-functioning neuroendocrine tumoursDisease-free survivalCareful clinical historyTreatment of choicePancreatic neuroendocrine tumorsQuality of lifeHormone hypersecretionMetastatic diseaseNonfunctional tumorsSurgical resectionTreatment modalitiesClinical historyPotential treatmentHeterogeneous groupTumorsMass effectAgeTreatmentLaboratory testsHypersecretionResectionPatientsFactors associated with complete clip closure after endoscopic mucosal resection of large colorectal polyps
Ortiz O, Rex DK, Grimm IS, Moyer MT, Hasan MK, Pleskow D, Elmunzer BJ, Khashab MA, Sanaei O, Al-Kawas FH, Gordon SR, Mathew A, Levenick JM, Aslanian H, Antaki F, von Renteln D, Crockett SD, Rastogi A, Gill JA, Law R, Wallace MB, Elias PA, MacKenzie TA, Pohl H, Pellisé M. Factors associated with complete clip closure after endoscopic mucosal resection of large colorectal polyps. Endoscopy 2021, 53: 1150-1159. PMID: 33291159, DOI: 10.1055/a-1332-6727.Peer-Reviewed Original ResearchConceptsEndoscopic mucosal resectionProphylactic clip closureLarge colorectal polypsClip closureMucosal defectsMucosal resectionColorectal polypsLarge polypsResection defectsComplete closureCommon adverse eventsSubmucosal liftingAdverse eventsBloc resectionMultivariable analysisProximal polypsSerrated histologyClip groupMAIN OUTCOMECLIP studyStudy aimPolyp sizeResectionPolypsPatients
2020
Sa1027 EVALUATION OF SOCIOECONOMIC AND HEALTHCARE DISPARITIES ON SAME-ADMISSION CHOLECYSTECTOMY AFTER ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY AMONG PATIENTS WITH ACUTE GALLSTONE PANCREATITIS
Chouairi F, McCarty T, Hathorn K, Sharma P, Aslanian H, Thompson C, Jamidar P, Muniraj T. Sa1027 EVALUATION OF SOCIOECONOMIC AND HEALTHCARE DISPARITIES ON SAME-ADMISSION CHOLECYSTECTOMY AFTER ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY AMONG PATIENTS WITH ACUTE GALLSTONE PANCREATITIS. Gastroenterology 2020, 158: s-247-s-248. DOI: 10.1016/s0016-5085(20)31302-0.Peer-Reviewed Original ResearchPancreatic Neuroendocrine Tumors
Muniraj T, Aslanian H. Pancreatic Neuroendocrine Tumors. 2020, 1-19. DOI: 10.1007/978-3-319-90761-1_81-1.Peer-Reviewed Original ResearchNeuroendocrine tumorsProlongs disease-free survivalDiagnosis of NETsNon-functioning neuroendocrine tumoursDisease-free survivalCareful clinical historyTreatment of choicePancreatic neuroendocrine tumorsQuality of lifeHormone hypersecretionMetastatic diseaseNonfunctional tumorsSurgical resectionTreatment modalitiesClinical historyPotential treatmentHeterogeneous groupTumorsMass effectAgeTreatmentLaboratory testsHypersecretionResectionPatients
2018
Safety and rate of delayed adverse events with lumen-apposing metal stents (LAMS) for pancreatic fluid collections: a multicenter study
Yang D, Perbtani Y, Mramba L, Kerdsirichairat T, Prabhu A, Manvar A, Ho S, Pannu D, Keswani R, Strand D, Wang A, Quintero E, Buscaglia J, Muniraj T, Aslanian H, Draganov P, Siddiqui A. Safety and rate of delayed adverse events with lumen-apposing metal stents (LAMS) for pancreatic fluid collections: a multicenter study. Endoscopy International Open 2018, 06: e1267-e1275. PMID: 30302385, PMCID: PMC6175687, DOI: 10.1055/a-0732-502.Peer-Reviewed Original ResearchLumen-apposing metal stentsPancreatic fluid collectionsAdverse eventsTreatment failureStent occlusionFluid collectionMetal stentsLogistic regressionMulticenter retrospective analysisProcedure-related factorsSymptomatic pancreatic fluid collectionsConsecutive patientsMulticenter studyEndoscopic ultrasoundEndoscopic drainageLower incidenceRetrospective analysisMAIN OUTCOMELAMS removalPatientsPFC resolutionLAMS placementOnly factorSole predictorStents
2010
T1453: Utility of EGD Prior to EUS in Patients Undergoing EUS for Pancreato-Biliary and Mediastinal Indications
Sanchez M, Adimoolam V, Rossi F, Padda M, Elmi F, Aslanian H, Siddiqui U. T1453: Utility of EGD Prior to EUS in Patients Undergoing EUS for Pancreato-Biliary and Mediastinal Indications. Gastrointestinal Endoscopy 2010, 71: ab281. DOI: 10.1016/j.gie.2010.03.666.Peer-Reviewed Original ResearchPatients